Perspectives for the chemotherapy of respiratory syncytial virus (RSV) infections (Q44967728)

7 December 2017

title

Perspectives for the chemotherapy of respiratory syncytial virus (RSV) infections (English)

1 reference

7 December 2017

1 reference

De Clercq E

1

1 reference

7 December 2017

publication date

1 August 1996

1 reference

International Journal of Antimicrobial Agents

7 December 2017

published in

1 reference

7 December 2017

volume

7

1 reference

7 December 2017

issue

3

1 reference

7 December 2017

page(s)

193-202

1 reference

Mixed viral infections: detection and management

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900319-6

7 January 2021

Viral respiratory infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900319-6

7 January 2021

Treatment of respiratory syncytial virus infections in children

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900319-6

7 January 2021

Early ribavirin treatment of respiratory syncytial viral infection in high-risk children

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900319-6

7 January 2021

A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900319-6

7 January 2021

High-dose, short-duration ribavirin aerosol therapy compared with standard ribavirin therapy in children with suspected respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900319-6

7 January 2021

Pediatric critical care physicians' attitudes about guidelines for the use of ribavirin in critically ill children with respiratory syncytial virus pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900319-6

7 January 2021

Historical cohort evaluation of ribavirin efficacy in respiratory syncytial virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900319-6

7 January 2021

Differential inhibitory effects of sulfated polysaccharides and polymers on the replication of various myxoviruses and retroviruses, depending on the composition of the target amino acid sequences of the viral envelope glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900319-6

7 January 2021

Inhibition of respiratory syncytial virus by bis(5-amidino-2-benzimidazolyl)methane

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900319-6

7 January 2021

Inhibition of respiratory syncytial virus-host cell interactions by mono- and diamidines

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900319-6

7 January 2021

S-adenosylhomocysteine hydrolase inhibitors as broad-spectrum antiviral agents

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900319-6

7 January 2021

Inhibitory effects of antiviral compounds on respiratory syncytial virus replication in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900319-6

7 January 2021

Synthesis and antiviral activity of 5'-deoxypyrazofurin

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900319-6

7 January 2021

Inhibition of replication of human respiratory syncytial virus by 6-diazo-5-oxo-L-norleucine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900319-6

7 January 2021

Synthesis and antiviral activity evaluation of some aminoadamantane derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900319-6

7 January 2021

Antiviral activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4- carboxamide and related compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900319-6

7 January 2021

Antiviral activities of ribavirin, 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide, and 6'-(R)-6'-C-methylneplanocin A against several ortho- and paramyxoviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900319-6

7 January 2021

Activity of a Sulfated Polysaccharide Extracted from the Red Seaweed Aghardhiella Tenera against Human Immunodeficiency Virus and Other Enveloped Viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900319-6

7 January 2021

Antiviral activity of a sulphated polysaccharide from the red seaweed Nothogenia fastigiata

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900319-6

7 January 2021

New Polyacetal Polysulphate Active against Human Immunodeficiency Virus and other Enveloped Viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900319-6

7 January 2021

In vitro and in vivo inhibition of ortho- and paramyxovirus infections by a new class of sulfonic acid polymers interacting with virus-cell binding and/or fusion

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900319-6

7 January 2021

Differential antiviral activity of derivatized dextrans

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900319-6

7 January 2021

Synthesis and antiviral evaluation of N-carboxamidine-substituted analogues of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamidine hydrochloride

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900319-6

7 January 2021

New neplanocin analogues. 1. Synthesis of 6'-modified neplanocin A derivatives as broad-spectrum antiviral agents

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900319-6

7 January 2021

Broad-spectrum antiviral and cytocidal activity of cyclopentenylcytosine, a carbocyclic nucleoside targeted at CTP synthetase

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900319-6

7 January 2021

Broad-spectrum antiviral activity of carbodine, the carbocyclic analogue of cytidine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900319-6

7 January 2021

Synthesis and antiviral properties of (+/-)-5'-noraristeromycin and related purine carbocyclic nucleosides. A new lead for anti-human cytomegalovirus agent design

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900319-6

7 January 2021

Antiviral enantiomeric preference for 5'-noraristeromycin.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900319-6

7 January 2021

An epimer of 5'-noraristeromycin and its antiviral properties.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900319-6

7 January 2021

3-deaza- and 7-deaza-5'-noraristeromycin and their antiviral properties

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900319-6

7 January 2021

Sulfonic acid polymers as a new class of human immunodeficiency virus inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900319-6

7 January 2021

Inhibitory effect of selected antiviral compounds on arenavirus replication in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900319-6

7 January 2021

Comparative activities of several nucleoside analogs against influenza A, B, and C viruses in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900319-6

7 January 2021

In vivo inhibition of respiratory syncytial virus by ribavirin

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900319-6

7 January 2021

Suppression of respiratory syncytial virus infection in cotton rats by bis(5-amidino-2-benzimidazolyl)methane

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900319-6

7 January 2021

Efficacy of high dose-short duration ribavirin aerosol in the treatment of respiratory syncytial virus infected cotton rats and influenza B virus infected mice

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900319-6

7 January 2021

SP-303 small-particle aerosol treatment of influenza A virus infection in mice and respiratory syncytial virus infection in cotton rats

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900319-6

7 January 2021

Further studies with short duration ribavirin aerosol for the treatment of influenza virus infection in mice and respiratory syncytial virus infection in cotton rats

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900319-6

7 January 2021

Intranasal monoclonal immunoglobulin A against respiratory syncytial virus protects against upper and lower respiratory tract infections in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900319-6

7 January 2021

HIV resistance to reverse transcriptase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900319-6

7 January 2021

Toward improved anti-HIV chemotherapy: therapeutic strategies for intervention with HIV infections

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900319-6

7 January 2021

Effects of ribavirin on respiratory syncytial virus in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2896%2900319-6

7 January 2021

10.1016/S0924-8579(96)00319-6

Identifiers

DOI

0 references

1 reference